Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12613000850774
Ethics application status
Approved
Date submitted
11/07/2013
Date registered
1/08/2013
Date last updated
5/08/2013
Type of registration
Retrospectively registered

Titles & IDs
Public title
Comparison of normobaric hypoxia and hypoxic hypoxia protocol on human performance and physiology
Scientific title
In young male population, is there difference in physiology, performance and hypoxia symptoms between normobaric hypoxia and hypobaric hypoxia?
Secondary ID [1] 282810 0
Nil
Universal Trial Number (UTN)
U1111-1145-5064
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
symptoms and physiological changes under hypoxia in healthy young male 289585 0
Condition category
Condition code
Respiratory 289921 289921 0 0
Other respiratory disorders / diseases

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
normobaric hypoxia: subjects in sitting position, exposed to hypoxia by inhaling 7% oxygen through face mask at sea level
hypoxia duration < 5 min (depend on invidual tolerance and SpO2)
Each participant undergo the two sessions on one occasion only. Each sessions are separated by at least 48 hours.
Intervention code [1] 287494 0
Other interventions
Comparator / control treatment
hypobaric hypoxia: subjects sitting in altitude chamber, exposed to hypoxia by ascending to simulated 25,000 feet environment; total duration of hypoxia exposure in altitude chamber varies in each individual but around 3-5 min (depend on invidivual tolerance and SpO2). All participants undergo this intervention on one occasion only.
Control group
Active

Outcomes
Primary outcome [1] 289974 0
PaO2 drop below 60% (evaluated by pulse oximeter with sensor attached to subjects' middle finger)
Timepoint [1] 289974 0
between 3-4 minutes of hypoxia exposure
Primary outcome [2] 289975 0
unable to hold on to hypoxia exposure (subjective feeling of participants, also judged by inside observer [aerospace physiologist])
Timepoint [2] 289975 0
3-4 minutes of hypoxia exposure
Primary outcome [3] 289976 0
heart rate drop > 20 bpm (monitored by polysomograph, with three EKG sensors over chest region)
Timepoint [3] 289976 0
3-4 minutes after hypoxia exposure
Secondary outcome [1] 303691 0
severe hypoxia symptoms (observed by aviation physiologist, combined with subjective check list with 17 hypoxia symptom items filled out by participants)
Timepoint [1] 303691 0
3-4 minutes after hypoxia exposure

Eligibility
Key inclusion criteria
healthy volunteer
able to detect middle cerebral artery blood flow by doppler at temporal region.
Minimum age
20 Years
Maximum age
40 Years
Sex
Males
Can healthy volunteers participate?
Yes
Key exclusion criteria
1. pulmonary disease (asthma, COPD, pneumothorax, pulmonary tuberculosis)
2. claustrophobia
3. heart disease
4. severe anemia

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Healthy volunteers were recruited from staff and trainees taking aviation physiology course in Aviation Physiology Research Laboratory of Kaoshiung Armed Forces Hospital Gangshan Branch. Inclusion criteria include: male between 20 to 40 years old and successful sonographic detection of blood flow signals in the middle cerebral artery using transcranial Doppler sonography. No female subjects were enrolled in order to minimize gender-related variability.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Each subject was asked to complete the NH and HH sessions in a randomized order. A list of random numbers was determined using a computer program (Research Randomizer). Numbers were placed in sealed opaque envelopes before the beginning of the study so that randomization was concealed from the recruiter.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Crossover
Other design features
within group study
Phase
Not Applicable
Type of endpoint/s
Safety
Statistical methods / analysis
Data were presented as mean+/-standard deviation. Statistical analysis wereperformed using generalized linear model (GzLM) and generalized equation estimation (GEE). Coreelation analysis was performed with Pearson analysis.
Data analysis was performed using the Statistical Package for the Social Sciences (SPSS; version 19.0, SPSS,USA). Results were considered significant when p<0.05.The sample size was calculated using G*power. With an a of 0.05, power of 0.80, and effect size of 0.5, required number of valid samples was at least 16.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
1/08/2012
Actual
3/08/2012
Date of last participant enrolment
Anticipated
31/10/2012
Actual
25/10/2012
Date of last data collection
Anticipated
Actual
Sample size
Target
21
Accrual to date
Final
Recruitment outside Australia
Country [1] 5182 0
Taiwan, Province Of China
State/province [1] 5182 0

Funding & Sponsors
Funding source category [1] 287589 0
University
Name [1] 287589 0
National Defense Medical Center
Country [1] 287589 0
Taiwan, Province Of China
Primary sponsor type
University
Name
National Defense Medical Center
Address
161 Minchuan East Road, Sec. 6, Taipei 11490, Taiwan, R.O.C.
Country
Taiwan, Province Of China
Secondary sponsor category [1] 286336 0
None
Name [1] 286336 0
Address [1] 286336 0
Country [1] 286336 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 289563 0
Institutional Review Board, Tri-Service General Hospital
Ethics committee address [1] 289563 0
Ethics committee country [1] 289563 0
Taiwan, Province Of China
Date submitted for ethics approval [1] 289563 0
21/06/2013
Approval date [1] 289563 0
30/07/2012
Ethics approval number [1] 289563 0
2-101-05-080

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 41334 0
Dr Hsin Chu
Address 41334 0
Institute of Aerospace and Undersea Medicine, School of Medicine, National Defense Medical Center.

No. 161, Section 6, Min-Chuan East Road. Taipei, 114 Taiwan, R.O.C.
Country 41334 0
Taiwan, Province Of China
Phone 41334 0
+886-2-87923100
Fax 41334 0
+886-2-87923176
Email 41334 0
[email protected]
Contact person for public queries
Name 41335 0
Hsin Chu
Address 41335 0
Institute of Aerospace and Undersea Medicine, School of Medicine, National Defense Medical Center.

No. 161, Section 6, Min-Chuan East Road. Taipei, 114 Taiwan, R.O.C.
Country 41335 0
Taiwan, Province Of China
Phone 41335 0
+886-2-87923100
Fax 41335 0
Email 41335 0
[email protected]
Contact person for scientific queries
Name 41336 0
Hsin Chu
Address 41336 0
Institute of Aerospace and Undersea Medicine, School of Medicine, National Defense Medical Center.

No. 161, Section 6, Min-Chuan East Road. Taipei, 114 Taiwan, R.O.C.
Country 41336 0
Taiwan, Province Of China
Phone 41336 0
+886-2-87923100
Fax 41336 0
Email 41336 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.